Intravenous administration of lipid emulsions to premature infants.
This article describes the mechanisms responsible for hydrolysis and clearance of triglyceride from the circulation and focuses on the factors that affect lipid clearance in the newborn infant. The potential beneficial and adverse effects of IV lipid administration to premature infants are reviewed in detail. Several practical considerations for IV lipid administration are also discussed.
D001663:Bilirubin / Q000378:metabolism; D001777:Blood Coagulation / Q000187:drug effects; D002331:Carnitine / Q000378:metabolism; D005217:Fat Emulsions, Intravenous / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D005228:Fatty Acids, Essential / Q000172:deficiency; D005947:Glucose / Q000378:metabolism; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007227:Infant Nutritional Physiological Phenomena; D007231:Infant, Newborn; D007234:Infant, Premature; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000098:blood supply; D009584:Nitrogen / Q000378:metabolism; D010100:Oxygen / Q000097:blood
D005217:Fat Emulsions, Intravenous; D005228:Fatty Acids, Essential; D006493:Heparin; D005947:Glucose; D009584:Nitrogen; D001663:Bilirubin; D002331:Carnitine; D010100:Oxygen